UAB "Loiterio bioimunologijos servisas" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 201,005 |
| 50,504 |
| 56,257 |
| -56,257 |
| -14,135 |
| -62.33 |
| -27.99 |
| 3,293,333 |
| 238,166 |
| 202,258 |
| 3,326,279 |
| 2024 |
|---|
| 0 |
| 0 |
| 31,965 |
| -31,965 |
| -10,655 |
| - |
| - |
| 3,261,368 |
| 249,583 |
| 189,758 |
| 3,319,767 |
| 2025 |
|---|
| 0 |
| 0 |
| 4,690 |
| 3,940 |
| 1,970 |
| - |
| - |
| 3,265,308 |
| 48,628 |
| 190,260 |
| 3,123,227 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 0 |
| 0 |
| 4,690 |
| 3,940 |
| 1,970 |
| - |
| - |
| 3,265,308 |
| 48,628 |
| 190,260 |
| 3,123,227 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
0 €- *
Sales per employee (€)
0 €- *
Profit before tax (€)
4,690 €-85 % *
Net Profit (€)
3,940 €112 % *
Profit per employee (€)
1,970 €118 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
3,265,308 €0 % *
Amounts Payable And Liabilities (€)
48,628 €-81 % *
Non-current Assets (€)
190,260 €0 % *
CurrentAssets (€)
3,123,227 €-6 % *
